91 related articles for article (PubMed ID: 29680102)
1. What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients' Quality of Life?
Lloyd AJ; Dewilde S; Noble S; Reimer E; Lee AYY
Value Health; 2018 Apr; 21(4):449-455. PubMed ID: 29680102
[TBL] [Abstract][Full Text] [Related]
2. Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial.
Burggraaf-van Delft JLI; van Rein N; Bemelmans RHH; van den Berg JK; Bruggeman CY; Cloos-van Balen M; Coppens M; Eefting M; Ende-Verhaar Y; van Es N; van Guldener C; de Jong WK; Kleijwegt F; Koster T; Kroon C; Kuipers S; Leentjens J; Luijten D; Mairuhu ATA; Meijer K; van de Ree MA; Roos R; Schrover I; Swart-Heikens J; van der Velden AWG; van den Akker-van Marle EM; le Cessie S; Geersing GJ; Middeldorp S; Huisman MV; Klok FA; Cannegieter SC;
BMJ Open; 2024 Mar; 14(3):e078676. PubMed ID: 38521524
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease.
Cohen AT; Noxon V; Dhamane AD; Shah S; Hines DM; Alfred T; Chaves J; Luo X
Curr Med Res Opin; 2024 Mar; 40(3):545-553. PubMed ID: 38332714
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cancer-associated venous thromboembolism in patients under palliative care.
Debourdeau P; Sevestre MA; Bertoletti L; Mayeur D; Girard P; Scotté F; Sanchez O; Mahé I;
Arch Cardiovasc Dis; 2024 Jan; 117(1):94-100. PubMed ID: 38072741
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in elderly patients with venous thromboembolism assessed using patient-reported outcome measures.
Deschamps J; Choffat D; Limacher A; Righini M; Beer JH; Baumgartner C; Hugli O; Aujesky D; Méan M
J Thromb Haemost; 2023 Nov; 21(11):3193-3202. PubMed ID: 37579877
[TBL] [Abstract][Full Text] [Related]
6. Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment.
Ten Cate V; Essers BA; Prins MH
BMJ Open; 2017 May; 7(5):e015231. PubMed ID: 28495816
[TBL] [Abstract][Full Text] [Related]
7. Developing a machine learning model for bleeding prediction in patients with cancer-associated thrombosis receiving anticoagulation therapy.
Grdinic AG; Radovanovic S; Gleditsch J; Jørgensen CT; Asady E; Pettersen HH; Delibasic B; Ghanima W
J Thromb Haemost; 2024 Apr; 22(4):1094-1104. PubMed ID: 38184201
[TBL] [Abstract][Full Text] [Related]
8. Measurement of adherence and health-related quality of life during anticoagulation therapy in cancer-associated venous thromboembolism (VTE): a multicenter quantitative study.
Font C; Gomez-Mesa JE; López-Núñez JJ; Calderón C; Galindo-Coral S; Wu CC; Ma J; Kroll MH; Rojas-Hernandez CM
Support Care Cancer; 2023 Oct; 31(10):615. PubMed ID: 37801086
[TBL] [Abstract][Full Text] [Related]
9. Decrements in health-related quality of life associated with adverse events in people with diabetes.
Keng MJ; Leal J; Bowman L; Armitage J; Mihaylova B;
Diabetes Obes Metab; 2022 Mar; 24(3):530-538. PubMed ID: 34866309
[TBL] [Abstract][Full Text] [Related]
10. Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study.
Ashrani AA; Silverstein MD; Rooke TW; Lahr BD; Petterson TM; Bailey KR; Melton LJ; Heit JA
Vasc Med; 2010 Oct; 15(5):387-97. PubMed ID: 20926498
[TBL] [Abstract][Full Text] [Related]
11. Management of cancer-associated venous thromboembolism from diagnosis to treatment: State of the art and remaining unmet needs.
Carrier M; Wang TF
Arch Cardiovasc Dis; 2024 Jan; 117(1):1-2. PubMed ID: 38008658
[No Abstract] [Full Text] [Related]
12. Thrombocytopenia and bleeding events in patients with venous thromboembolism.
Ito S; Inoko M; Yamashita Y; Morimoto T; Kimura T;
Eur J Intern Med; 2024 Apr; 122():132-134. PubMed ID: 38238133
[No Abstract] [Full Text] [Related]
13. Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved.
Roldán V; Soler-Espejo E; Marin F
Thromb Haemost; 2024 Apr; 124(4):337-339. PubMed ID: 37696302
[No Abstract] [Full Text] [Related]
14. Management of venous thromboembolism in cancer patients according to guidelines after educative measures.
Pillet A; Minne F; Belhadj Chaidi R; Chapelle G; Ferru A
Bull Cancer; 2018 May; 105(5):486-492. PubMed ID: 29680153
[TBL] [Abstract][Full Text] [Related]
15. Deep Vein Thrombosis in Europe-Health-Related Quality of Life and Mortality.
Monreal M; Agnelli G; Chuang LH; Cohen AT; Gumbs PD; Bauersachs R; Mismetti P; Gitt AK; Kroep S; Willich SN; Van Hout B
Clin Appl Thromb Hemost; 2019; 25():1076029619883946. PubMed ID: 31840534
[TBL] [Abstract][Full Text] [Related]
16. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).
Young AM; Marshall A; Thirlwall J; Chapman O; Lokare A; Hill C; Hale D; Dunn JA; Lyman GH; Hutchinson C; MacCallum P; Kakkar A; Hobbs FDR; Petrou S; Dale J; Poole CJ; Maraveyas A; Levine M
J Clin Oncol; 2018 Jul; 36(20):2017-2023. PubMed ID: 29746227
[TBL] [Abstract][Full Text] [Related]
17. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G; Becattini C; Meyer G; Muñoz A; Huisman MV; Connors JM; Cohen A; Bauersachs R; Brenner B; Torbicki A; Sueiro MR; Lambert C; Gussoni G; Campanini M; Fontanella A; Vescovo G; Verso M;
N Engl J Med; 2020 Apr; 382(17):1599-1607. PubMed ID: 32223112
[TBL] [Abstract][Full Text] [Related]
18. Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial.
McBane RD; Loprinzi CL; Ashrani A; Lenz CJ; Houghton D; Zemla T; Le-Rademacher JG; Wysokinski WE
Eur J Haematol; 2020 Feb; 104(2):88-96. PubMed ID: 31606897
[TBL] [Abstract][Full Text] [Related]
19. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Frere C; Connors JM; Ay C; Khorana AA; Munoz A; Brenner B; Kakkar A; Rafii H; Solymoss S; Brilhante D; Monreal M; Bounameaux H; Pabinger I; Douketis J;
Lancet Oncol; 2019 Oct; 20(10):e566-e581. PubMed ID: 31492632
[TBL] [Abstract][Full Text] [Related]
20. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.
Key NS; Khorana AA; Kuderer NM; Bohlke K; Lee AYY; Arcelus JI; Wong SL; Balaban EP; Flowers CR; Francis CW; Gates LE; Kakkar AK; Levine MN; Liebman HA; Tempero MA; Lyman GH; Falanga A
J Clin Oncol; 2020 Feb; 38(5):496-520. PubMed ID: 31381464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
